Your browser doesn't support javascript.
loading
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.
Koie, Takuya; Ohyama, Chikara; Yoneyama, Takahiro; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Hashimoto, Yasuhiro; Yoneyama, Tohru; Tobisawa, Yuki; Mori, Kazuyuki.
Afiliação
  • Koie T; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. goodwin@cc.hirosaki-u.ac.jp.
  • Ohyama C; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. coyama@cc.hirosaki-u.ac.jp.
  • Yoneyama T; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. uroyone@cc.hirosaki-u.ac.jp.
  • Yamamoto H; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. ha-yama@cc.hirosaki-u.ac.jp.
  • Imai A; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. tsushi.imai@gmail.com.
  • Hatakeyama S; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. shingorilla2@gmail.com.
  • Hashimoto Y; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. y-hashi@cc.hirosaki-u.ac.jp.
  • Yoneyama T; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. tohruyon@cc.hirosaki-u.ac.jp.
  • Tobisawa Y; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. tobisawa@cc.hirosaki-u.ac.jp.
  • Mori K; Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, 036-8562, Japan. moribio@cc.hirosaki-u.ac.jp.
BMC Urol ; 15: 32, 2015 Apr 16.
Article em En | MEDLINE | ID: mdl-25887125

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Imidazóis / Indazóis / Neoplasias Renais Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Imidazóis / Indazóis / Neoplasias Renais Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão